Cite
Development of a PET/CT molecular radiomics-clinical model to predict thoracic lymph node metastasis of invasive lung adenocarcinoma ≤ 3 cm in diameter.
MLA
Chang, Cheng, et al. “Development of a PET/CT Molecular Radiomics-Clinical Model to Predict Thoracic Lymph Node Metastasis of Invasive Lung Adenocarcinoma ≤ 3 Cm in Diameter.” EJNMMI Research, vol. 12, no. 1, Apr. 2022, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s13550-022-00895-x.
APA
Chang, C., Ruan, M., Lei, B., Yu, H., Zhao, W., Ge, Y., Duan, S., Teng, W., Wu, Q., Qian, X., Wang, L., Yan, H., Liu, C., Liu, L., Feng, J., & Xie, W. (2022). Development of a PET/CT molecular radiomics-clinical model to predict thoracic lymph node metastasis of invasive lung adenocarcinoma ≤ 3 cm in diameter. EJNMMI Research, 12(1), 1–11. https://doi.org/10.1186/s13550-022-00895-x
Chicago
Chang, Cheng, Maomei Ruan, Bei Lei, Hong Yu, Wenlu Zhao, Yaqiong Ge, Shaofeng Duan, et al. 2022. “Development of a PET/CT Molecular Radiomics-Clinical Model to Predict Thoracic Lymph Node Metastasis of Invasive Lung Adenocarcinoma ≤ 3 Cm in Diameter.” EJNMMI Research 12 (1): 1–11. doi:10.1186/s13550-022-00895-x.